Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine

JAMA Dermatology

Volumn 149, Issue 3, 2013, Pages 370-372

  Daniel, Benjamin S ^a   Murrell, Dedee F ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; IMIQUIMOD; SULFOSALICYLIC ACID; WART VIRUS VACCINE;

ABSENCE OF SIDE EFFECTS; ADULT; CASE REPORT; CHILD; CHRONIC DISEASE; CRYOTHERAPY; DOSE TIME EFFECT RELATION; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LETTER; MALE; OFF LABEL DRUG USE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; VERRUCA VULGARIS;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PAPILLOMAVIRUS VACCINES; TREATMENT OUTCOME; WARTS; YOUNG ADULT;

EID: 84875392838     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.1463     Document Type: Letter

References (4)

1. Gibbs S, Harvey I. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2006;3(3):CD001781.
2. Nai-Ming L, Yuk-Ming William T. Warts (non-genital). Clin Evid (Online). 2007.
3. Loo SK, Tang WY. Warts (non-genital). Clin Evid (Online). 2009.
4. Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol. 2010;146(5):475-477.